Dr. Reddy's Laboratories’ arm recalling 37,560 bottles of Tizanidine HCl tablets

31 Aug 2021 Evaluate

Dr. Reddy's Laboratories’ US subsidiary -- Dr Reddy's Laboratories, Inc is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg, the latest enforcement report by the US Food and Drug Administration (USFDA). The tablets are manufactured by Dr Reddy's Laboratories at its Srikakulam facility. The product is used to treat the symptoms of muscle stiffness associated with conditions such as cerebral palsy or other neurological disorders.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

5882.45 9.80 (0.17%)
23-May-2024 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1494.95
Dr. Reddys Lab 5882.45
Cipla 1487.45
Zydus Lifesciences 1087.65
Lupin 1631.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.